74 related articles for article (PubMed ID: 22614725)
1. On the relevance of glycolysis process on brain gliomas.
Kounelakis MG; Zervakis ME; Giakos GC; Postma GJ; Buydens LM; Kotsiakis X
IEEE J Biomed Health Inform; 2013 Jan; 17(1):128-35. PubMed ID: 22614725
[TBL] [Abstract][Full Text] [Related]
2. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
Bredel M; Pollack IF; Hamilton RL; James CD
Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083
[TBL] [Abstract][Full Text] [Related]
4. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
5. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.
Oudard S; Boitier E; Miccoli L; Rousset S; Dutrillaux B; Poupon MF
Anticancer Res; 1997; 17(3C):1903-11. PubMed ID: 9216643
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
7. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
Ziegler A; von Kienlin M; Décorps M; Rémy C
Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
[TBL] [Abstract][Full Text] [Related]
8. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
9. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profile as a prognostic factor in high-grade gliomas.
Czernicki T; Zegarska J; Paczek L; Cukrowska B; Grajkowska W; Zajaczkowska A; Brudzewski K; Ulaczyk J; Marchel A
Int J Oncol; 2007 Jan; 30(1):55-64. PubMed ID: 17143512
[TBL] [Abstract][Full Text] [Related]
11. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
Viapiano MS; Bi WL; Piepmeier J; Hockfield S; Matthews RT
Cancer Res; 2005 Aug; 65(15):6726-33. PubMed ID: 16061654
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
13. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
14. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
15. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
16. Deregulated expression of the clock genes in gliomas.
Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of gliomas strongly predicts survival.
Freije WA; Castro-Vargas FE; Fang Z; Horvath S; Cloughesy T; Liau LM; Mischel PS; Nelson SF
Cancer Res; 2004 Sep; 64(18):6503-10. PubMed ID: 15374961
[TBL] [Abstract][Full Text] [Related]
18. [Molecular biology in cerebral gliomas: recent advances].
Hoang-Xuan K; Li YJ; Hamelin R; Delattre O
Rev Neurol (Paris); 1995 Nov; 151(11):608-18. PubMed ID: 8745624
[TBL] [Abstract][Full Text] [Related]
19. [Targeting the gene of glucose metabolism for the treatment of advanced gliomas].
Oudard S; Miccoli L; Dutrillaux B; Poupon MF
Bull Cancer; 1998 Jul; 85(7):622-6. PubMed ID: 9752269
[TBL] [Abstract][Full Text] [Related]
20. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]